Top Companies in Monoclonal Antibodies Market | Industry Top Companies In-depth Analysis by Vantage Market Research
Monoclonal Antibodies are used widely in immunotherapy where they attach mono to specific proteins and cells.
Coralia.Joe
Market Overview:
The Global Monoclonal Antibodies Market is valued at USD 105.2 Billion in the year 2021 and is anticipated to reach a value of USD 155.2 Billion by the year 2028. The Global Market is forecasted to grow to exhibit a Compound Annual Growth Rate (CAGR) of 6.7% over the forecast period.
Monoclonal Antibodies Market includes sales of Monoclonal Antibodies and correlated services. Monoclonal Antibodies are used to increase and suppress the immune response in numerous medical conditions and to treat numerous diseases such as cancer, and cardiovascular and cerebrovascular diseases. The industry primarily consists of an initiation that produces anti-cancer Monoclonal Antibodies to hamper metastasis by decreasing cell proliferation, immunological monoclonal anti-bodies, neuro-pharmacological monoclonal anti-bodies, and anti-infective Monoclonal Antibodies and other Monoclonal Antibodies for human beings & animals.
The main classification causes of Monoclonal Antibodies are murine, chimeric, humanized, and human. A murine antibody has two components of chains, the first one which is from a mouse and the other from a human. The pre-stem in a murine antibody's INN is driven to recognize it. It is used in anti-cancer, immunological, anti-infective, Monoclonal Antibodies, neuro-pharmacological, cardiovascular and cerebrovascular, and others and implemented in numerous sections such as hospitals, private clinics, and research institutes.
Get Access to Our Free Sample Report: https://www.vantagemarketresearch.com/monoclonal-antibodies-market-1673/request-sample
Some of the key players operating in the Monoclonal Antibodies Market are listed below:
|
Company Name |
Revenue in the US |
|
$93 Billion |
|
$25 Billion |
|
$69 Billion |
|
$71 Billion |
|
$52 Billion |
|
$43 Billion |
|
$32 Billion |
|
$1 Billion |
|
$48 Billion |
|
$52 Billion |
Johnson & Johnson is a holding company, which engages in the research and development, manufacture, and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The company was founded in 1886 and is headquartered in New Brunswick, New Jersey.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta which reduces the chance of infection due to a low white blood cell count in patients with cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves to its client base worldwide. It was founded in 1849 and its headquarters in New York, United States. The company is listed on NYSE.
Hoffmann-La Roche AG provides in-vitro diagnostics and drugs for cancer and transplantation. The Company specializes in medicines for oncology, virology, inflammation, metabolism, CNS, clinical chemistry, immunology, urinalysis, blood screening, genetics, infectious diseases, and microbiology. F. Hoffmann-La Roche operates in Switzerland. The company was founded in 1896.
Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment research, develops, manufactures, distributes, and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The company was founded in 1996 and is headquartered in Basel, Switzerland.
Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company's products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
AstraZeneca is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Their pipelines are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market, and distribution of generic, branded generic and specialty pharmaceutical products. The company was founded in 1961 and its headquarters are in Pennsylvania.
Bayer AG engages in the development, manufacture, and distribution of products in the areas of health care, nutrition, and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health, and Covestro. The Pharmaceuticals segment engages in the development, production, and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care, and sun protection categories. The company was founded in 1863 and its headquarters is in Germany.
Merck & Co. Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceuticals and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceuticals and vaccine products, for the prevention, treatment, and control of disease in livestock and companion animal species. The company was founded in 1891 and is headquartered in Kenilworth, NJ.
Read Latest Blog Top Companies in Medical Waste Management Market: https://v-mr.biz/medical-waste-management-market
Do You Have Any Query or Specific Requirements? You may enquire to our sales team before purchase.
Contact us
Eric Kunz
6218 Georgia Avenue NW Ste 1 - 564
Washington DC 20011-5125
United States Tel: +1 202 380 9727
Email: [email protected]
Website: https://www.vantagemarketresearch.com/
Follow Us on LinkedIn: https://www.linkedin.com/company/vantage-market-research/
Follow Us on Twitter: https://twitter.com/vantagemarketr
